Novartis Wins Judgment In Mylan Heart Drug Patent Fight
By Adam Lidgett · July 7, 2023, 1:45 PM EDT
A West Virginia federal judge said Mylan's proposed generic version of heart medication Entresto would infringe a pair of patents that Swiss pharmaceutical giant Novartis has on the brand-name product....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login